nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—ABCB1—lung cancer	0.121	1	CbGaD
Indinavir—ABCC1—Paclitaxel—lung cancer	0.0228	0.0366	CbGbCtD
Indinavir—ABCC1—Irinotecan—lung cancer	0.0225	0.0361	CbGbCtD
Indinavir—ABCC1—Vinblastine—lung cancer	0.02	0.0321	CbGbCtD
Indinavir—SLCO1B1—Irinotecan—lung cancer	0.019	0.0304	CbGbCtD
Indinavir—ABCC1—Etoposide—lung cancer	0.018	0.0289	CbGbCtD
Indinavir—ABCC2—Paclitaxel—lung cancer	0.0169	0.0271	CbGbCtD
Indinavir—ABCC2—Irinotecan—lung cancer	0.0167	0.0267	CbGbCtD
Indinavir—ABCC1—Docetaxel—lung cancer	0.0165	0.0264	CbGbCtD
Indinavir—CYP3A5—Gefitinib—lung cancer	0.0156	0.025	CbGbCtD
Indinavir—CYP3A5—Teniposide—lung cancer	0.0152	0.0243	CbGbCtD
Indinavir—ABCC2—Vinblastine—lung cancer	0.0148	0.0237	CbGbCtD
Indinavir—ABCC2—Cisplatin—lung cancer	0.0136	0.0218	CbGbCtD
Indinavir—ABCC2—Etoposide—lung cancer	0.0134	0.0214	CbGbCtD
Indinavir—CYP2C19—Gefitinib—lung cancer	0.0126	0.0202	CbGbCtD
Indinavir—ABCC1—Doxorubicin—lung cancer	0.0123	0.0197	CbGbCtD
Indinavir—CYP2C19—Teniposide—lung cancer	0.0122	0.0196	CbGbCtD
Indinavir—ABCC2—Docetaxel—lung cancer	0.0122	0.0196	CbGbCtD
Indinavir—ABCC1—Methotrexate—lung cancer	0.0119	0.0191	CbGbCtD
Indinavir—CYP3A7—Paclitaxel—lung cancer	0.0113	0.0181	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0113	0.0181	CbGbCtD
Indinavir—CYP3A7—Irinotecan—lung cancer	0.0111	0.0178	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0111	0.0178	CbGbCtD
Indinavir—ABCB1—Topotecan—lung cancer	0.0111	0.0178	CbGbCtD
Indinavir—SLCO1A2—Methotrexate—lung cancer	0.0106	0.017	CbGbCtD
Indinavir—CYP2C9—Gefitinib—lung cancer	0.0105	0.0168	CbGbCtD
Indinavir—ABCB1—Gefitinib—lung cancer	0.0102	0.0163	CbGbCtD
Indinavir—CYP2C9—Teniposide—lung cancer	0.0102	0.0163	CbGbCtD
Indinavir—SLCO1B1—Methotrexate—lung cancer	0.01	0.0161	CbGbCtD
Indinavir—CYP2D6—Gefitinib—lung cancer	0.00959	0.0154	CbGbCtD
Indinavir—CYP3A5—Crizotinib—lung cancer	0.00958	0.0154	CbGbCtD
Indinavir—CYP3A5—Erlotinib—lung cancer	0.00925	0.0148	CbGbCtD
Indinavir—ABCC2—Doxorubicin—lung cancer	0.00911	0.0146	CbGbCtD
Indinavir—ABCC2—Methotrexate—lung cancer	0.00882	0.0141	CbGbCtD
Indinavir—CYP3A5—Paclitaxel—lung cancer	0.00846	0.0136	CbGbCtD
Indinavir—CYP3A5—Irinotecan—lung cancer	0.00835	0.0134	CbGbCtD
Indinavir—CYP3A7—Docetaxel—lung cancer	0.00816	0.0131	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00816	0.0131	CbGbCtD
Indinavir—ABCB1—Vinorelbine—lung cancer	0.00784	0.0126	CbGbCtD
Indinavir—CYP2D6—Vinorelbine—lung cancer	0.00739	0.0118	CbGbCtD
Indinavir—CYP3A5—Etoposide—lung cancer	0.00669	0.0107	CbGbCtD
Indinavir—CYP3A4—Topotecan—lung cancer	0.00667	0.0107	CbGbCtD
Indinavir—ABCB1—Crizotinib—lung cancer	0.00624	0.00999	CbGbCtD
Indinavir—CYP3A5—Docetaxel—lung cancer	0.00612	0.0098	CbGbCtD
Indinavir—CYP3A4—Gefitinib—lung cancer	0.0061	0.00977	CbGbCtD
Indinavir—ABCB1—Gemcitabine—lung cancer	0.0061	0.00977	CbGbCtD
Indinavir—ABCB1—Erlotinib—lung cancer	0.00602	0.00964	CbGbCtD
Indinavir—CYP3A4—Teniposide—lung cancer	0.00591	0.00947	CbGbCtD
Indinavir—CYP2C9—Paclitaxel—lung cancer	0.00568	0.00909	CbGbCtD
Indinavir—CYP2D6—Erlotinib—lung cancer	0.00567	0.00908	CbGbCtD
Indinavir—ABCB1—Paclitaxel—lung cancer	0.00551	0.00882	CbGbCtD
Indinavir—ABCB1—Irinotecan—lung cancer	0.00543	0.0087	CbGbCtD
Indinavir—ABCB1—Vinblastine—lung cancer	0.00483	0.00774	CbGbCtD
Indinavir—CYP3A4—Vinorelbine—lung cancer	0.0047	0.00752	CbGbCtD
Indinavir—CYP2C9—Cisplatin—lung cancer	0.00456	0.00731	CbGbCtD
Indinavir—CYP2D6—Vinblastine—lung cancer	0.00455	0.00729	CbGbCtD
Indinavir—ABCB1—Cisplatin—lung cancer	0.00443	0.0071	CbGbCtD
Indinavir—ABCB1—Etoposide—lung cancer	0.00435	0.00697	CbGbCtD
Indinavir—ABCB1—Docetaxel—lung cancer	0.00398	0.00638	CbGbCtD
Indinavir—CYP3A4—Crizotinib—lung cancer	0.00374	0.00599	CbGbCtD
Indinavir—CYP3A4—Erlotinib—lung cancer	0.00361	0.00577	CbGbCtD
Indinavir—CYP3A4—Paclitaxel—lung cancer	0.0033	0.00529	CbGbCtD
Indinavir—CYP3A4—Irinotecan—lung cancer	0.00326	0.00522	CbGbCtD
Indinavir—ABCB1—Doxorubicin—lung cancer	0.00297	0.00476	CbGbCtD
Indinavir—CYP3A4—Vinblastine—lung cancer	0.00289	0.00464	CbGbCtD
Indinavir—ABCB1—Methotrexate—lung cancer	0.00288	0.00461	CbGbCtD
Indinavir—CYP2D6—Doxorubicin—lung cancer	0.0028	0.00448	CbGbCtD
Indinavir—CYP3A4—Etoposide—lung cancer	0.00261	0.00418	CbGbCtD
Indinavir—CYP3A4—Docetaxel—lung cancer	0.00239	0.00382	CbGbCtD
Indinavir—CYP3A4—Doxorubicin—lung cancer	0.00178	0.00285	CbGbCtD
Indinavir—Nelfinavir—ABCG2—lung cancer	0.000799	0.319	CrCbGaD
Indinavir—Saquinavir—ABCG2—lung cancer	0.000547	0.219	CrCbGaD
Indinavir—Lopinavir—ABCB1—lung cancer	0.000358	0.143	CrCbGaD
Indinavir—Nelfinavir—ABCB1—lung cancer	0.000332	0.133	CrCbGaD
Indinavir—Saquinavir—ALB—lung cancer	0.000239	0.0954	CrCbGaD
Indinavir—Saquinavir—ABCB1—lung cancer	0.000228	0.091	CrCbGaD
Indinavir—Hepatobiliary disease—Methotrexate—lung cancer	6.79e-05	0.000418	CcSEcCtD
Indinavir—Insomnia—Paclitaxel—lung cancer	6.78e-05	0.000417	CcSEcCtD
Indinavir—Hypersensitivity—Irinotecan—lung cancer	6.78e-05	0.000417	CcSEcCtD
Indinavir—Paraesthesia—Paclitaxel—lung cancer	6.73e-05	0.000414	CcSEcCtD
Indinavir—Dyspnoea—Paclitaxel—lung cancer	6.69e-05	0.000411	CcSEcCtD
Indinavir—Somnolence—Paclitaxel—lung cancer	6.67e-05	0.00041	CcSEcCtD
Indinavir—Decreased appetite—Etoposide—lung cancer	6.65e-05	0.000409	CcSEcCtD
Indinavir—Myalgia—Docetaxel—lung cancer	6.63e-05	0.000408	CcSEcCtD
Indinavir—Arthralgia—Docetaxel—lung cancer	6.63e-05	0.000408	CcSEcCtD
Indinavir—Chest pain—Docetaxel—lung cancer	6.63e-05	0.000408	CcSEcCtD
Indinavir—Nausea—Vinorelbine—lung cancer	6.62e-05	0.000407	CcSEcCtD
Indinavir—Gastrointestinal disorder—Etoposide—lung cancer	6.6e-05	0.000406	CcSEcCtD
Indinavir—Dyspepsia—Paclitaxel—lung cancer	6.6e-05	0.000406	CcSEcCtD
Indinavir—Body temperature increased—Cisplatin—lung cancer	6.6e-05	0.000406	CcSEcCtD
Indinavir—Asthenia—Irinotecan—lung cancer	6.6e-05	0.000406	CcSEcCtD
Indinavir—Fatigue—Etoposide—lung cancer	6.59e-05	0.000406	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	6.59e-05	0.000405	CcSEcCtD
Indinavir—Pain—Etoposide—lung cancer	6.54e-05	0.000402	CcSEcCtD
Indinavir—Constipation—Etoposide—lung cancer	6.54e-05	0.000402	CcSEcCtD
Indinavir—Dysuria—Doxorubicin—lung cancer	6.52e-05	0.000401	CcSEcCtD
Indinavir—Decreased appetite—Paclitaxel—lung cancer	6.52e-05	0.000401	CcSEcCtD
Indinavir—Dry mouth—Docetaxel—lung cancer	6.49e-05	0.000399	CcSEcCtD
Indinavir—Upper respiratory tract infection—Doxorubicin—lung cancer	6.48e-05	0.000399	CcSEcCtD
Indinavir—Haemoglobin—Methotrexate—lung cancer	6.48e-05	0.000399	CcSEcCtD
Indinavir—Gastrointestinal disorder—Paclitaxel—lung cancer	6.48e-05	0.000398	CcSEcCtD
Indinavir—Fatigue—Paclitaxel—lung cancer	6.47e-05	0.000398	CcSEcCtD
Indinavir—Haemorrhage—Methotrexate—lung cancer	6.45e-05	0.000397	CcSEcCtD
Indinavir—Hepatitis—Methotrexate—lung cancer	6.45e-05	0.000397	CcSEcCtD
Indinavir—Pollakiuria—Doxorubicin—lung cancer	6.45e-05	0.000396	CcSEcCtD
Indinavir—Asthenia—Gemcitabine—lung cancer	6.43e-05	0.000395	CcSEcCtD
Indinavir—Pain—Paclitaxel—lung cancer	6.41e-05	0.000395	CcSEcCtD
Indinavir—Constipation—Paclitaxel—lung cancer	6.41e-05	0.000395	CcSEcCtD
Indinavir—Pharyngitis—Methotrexate—lung cancer	6.4e-05	0.000394	CcSEcCtD
Indinavir—Urinary tract disorder—Methotrexate—lung cancer	6.37e-05	0.000392	CcSEcCtD
Indinavir—Anaphylactic shock—Docetaxel—lung cancer	6.36e-05	0.000391	CcSEcCtD
Indinavir—Oedema—Docetaxel—lung cancer	6.36e-05	0.000391	CcSEcCtD
Indinavir—Weight increased—Doxorubicin—lung cancer	6.35e-05	0.000391	CcSEcCtD
Indinavir—Pruritus—Gemcitabine—lung cancer	6.34e-05	0.00039	CcSEcCtD
Indinavir—Urethral disorder—Methotrexate—lung cancer	6.32e-05	0.000389	CcSEcCtD
Indinavir—Feeling abnormal—Etoposide—lung cancer	6.3e-05	0.000388	CcSEcCtD
Indinavir—Hyperglycaemia—Doxorubicin—lung cancer	6.29e-05	0.000387	CcSEcCtD
Indinavir—Diarrhoea—Irinotecan—lung cancer	6.29e-05	0.000387	CcSEcCtD
Indinavir—Pneumonia—Doxorubicin—lung cancer	6.26e-05	0.000385	CcSEcCtD
Indinavir—Gastrointestinal pain—Etoposide—lung cancer	6.26e-05	0.000385	CcSEcCtD
Indinavir—Shock—Docetaxel—lung cancer	6.25e-05	0.000385	CcSEcCtD
Indinavir—Nervous system disorder—Docetaxel—lung cancer	6.23e-05	0.000383	CcSEcCtD
Indinavir—Thrombocytopenia—Docetaxel—lung cancer	6.22e-05	0.000383	CcSEcCtD
Indinavir—Feeling abnormal—Paclitaxel—lung cancer	6.18e-05	0.00038	CcSEcCtD
Indinavir—Skin disorder—Docetaxel—lung cancer	6.17e-05	0.00038	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Doxorubicin—lung cancer	6.17e-05	0.000379	CcSEcCtD
Indinavir—Hypersensitivity—Cisplatin—lung cancer	6.15e-05	0.000378	CcSEcCtD
Indinavir—Gastrointestinal pain—Paclitaxel—lung cancer	6.13e-05	0.000377	CcSEcCtD
Indinavir—Diarrhoea—Gemcitabine—lung cancer	6.13e-05	0.000377	CcSEcCtD
Indinavir—Renal failure—Doxorubicin—lung cancer	6.11e-05	0.000376	CcSEcCtD
Indinavir—Erythema multiforme—Methotrexate—lung cancer	6.1e-05	0.000375	CcSEcCtD
Indinavir—Neuropathy peripheral—Doxorubicin—lung cancer	6.1e-05	0.000375	CcSEcCtD
Indinavir—Dizziness—Irinotecan—lung cancer	6.08e-05	0.000374	CcSEcCtD
Indinavir—Urticaria—Etoposide—lung cancer	6.08e-05	0.000374	CcSEcCtD
Indinavir—Jaundice—Doxorubicin—lung cancer	6.06e-05	0.000373	CcSEcCtD
Indinavir—Anorexia—Docetaxel—lung cancer	6.06e-05	0.000373	CcSEcCtD
Indinavir—Abdominal pain—Etoposide—lung cancer	6.05e-05	0.000372	CcSEcCtD
Indinavir—Body temperature increased—Etoposide—lung cancer	6.05e-05	0.000372	CcSEcCtD
Indinavir—Urinary tract infection—Doxorubicin—lung cancer	6.05e-05	0.000372	CcSEcCtD
Indinavir—Asthenia—Cisplatin—lung cancer	5.99e-05	0.000368	CcSEcCtD
Indinavir—Sweating—Doxorubicin—lung cancer	5.96e-05	0.000367	CcSEcCtD
Indinavir—Urticaria—Paclitaxel—lung cancer	5.96e-05	0.000366	CcSEcCtD
Indinavir—Haematuria—Doxorubicin—lung cancer	5.93e-05	0.000365	CcSEcCtD
Indinavir—Abdominal pain—Paclitaxel—lung cancer	5.93e-05	0.000365	CcSEcCtD
Indinavir—Body temperature increased—Paclitaxel—lung cancer	5.93e-05	0.000365	CcSEcCtD
Indinavir—Hepatobiliary disease—Doxorubicin—lung cancer	5.88e-05	0.000362	CcSEcCtD
Indinavir—Vomiting—Irinotecan—lung cancer	5.85e-05	0.00036	CcSEcCtD
Indinavir—Sinusitis—Doxorubicin—lung cancer	5.84e-05	0.000359	CcSEcCtD
Indinavir—Immune system disorder—Methotrexate—lung cancer	5.83e-05	0.000358	CcSEcCtD
Indinavir—Rash—Irinotecan—lung cancer	5.8e-05	0.000357	CcSEcCtD
Indinavir—Dermatitis—Irinotecan—lung cancer	5.79e-05	0.000356	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Docetaxel—lung cancer	5.79e-05	0.000356	CcSEcCtD
Indinavir—Chills—Methotrexate—lung cancer	5.79e-05	0.000356	CcSEcCtD
Indinavir—Headache—Irinotecan—lung cancer	5.76e-05	0.000354	CcSEcCtD
Indinavir—Insomnia—Docetaxel—lung cancer	5.75e-05	0.000354	CcSEcCtD
Indinavir—Diarrhoea—Cisplatin—lung cancer	5.71e-05	0.000351	CcSEcCtD
Indinavir—Paraesthesia—Docetaxel—lung cancer	5.71e-05	0.000351	CcSEcCtD
Indinavir—Alopecia—Methotrexate—lung cancer	5.7e-05	0.000351	CcSEcCtD
Indinavir—Vomiting—Gemcitabine—lung cancer	5.7e-05	0.00035	CcSEcCtD
Indinavir—Dyspnoea—Docetaxel—lung cancer	5.67e-05	0.000349	CcSEcCtD
Indinavir—Somnolence—Docetaxel—lung cancer	5.65e-05	0.000348	CcSEcCtD
Indinavir—Rash—Gemcitabine—lung cancer	5.65e-05	0.000347	CcSEcCtD
Indinavir—Dermatitis—Gemcitabine—lung cancer	5.64e-05	0.000347	CcSEcCtD
Indinavir—Hypersensitivity—Etoposide—lung cancer	5.64e-05	0.000347	CcSEcCtD
Indinavir—Malnutrition—Methotrexate—lung cancer	5.61e-05	0.000345	CcSEcCtD
Indinavir—Haemoglobin—Doxorubicin—lung cancer	5.61e-05	0.000345	CcSEcCtD
Indinavir—Headache—Gemcitabine—lung cancer	5.61e-05	0.000345	CcSEcCtD
Indinavir—Dyspepsia—Docetaxel—lung cancer	5.6e-05	0.000344	CcSEcCtD
Indinavir—Hepatitis—Doxorubicin—lung cancer	5.58e-05	0.000343	CcSEcCtD
Indinavir—Haemorrhage—Doxorubicin—lung cancer	5.58e-05	0.000343	CcSEcCtD
Indinavir—Hypoaesthesia—Doxorubicin—lung cancer	5.56e-05	0.000342	CcSEcCtD
Indinavir—Pharyngitis—Doxorubicin—lung cancer	5.54e-05	0.000341	CcSEcCtD
Indinavir—Decreased appetite—Docetaxel—lung cancer	5.53e-05	0.00034	CcSEcCtD
Indinavir—Hypersensitivity—Paclitaxel—lung cancer	5.53e-05	0.00034	CcSEcCtD
Indinavir—Urinary tract disorder—Doxorubicin—lung cancer	5.51e-05	0.000339	CcSEcCtD
Indinavir—Dysgeusia—Methotrexate—lung cancer	5.5e-05	0.000338	CcSEcCtD
Indinavir—Gastrointestinal disorder—Docetaxel—lung cancer	5.49e-05	0.000338	CcSEcCtD
Indinavir—Asthenia—Etoposide—lung cancer	5.49e-05	0.000338	CcSEcCtD
Indinavir—Connective tissue disorder—Doxorubicin—lung cancer	5.49e-05	0.000338	CcSEcCtD
Indinavir—Fatigue—Docetaxel—lung cancer	5.48e-05	0.000337	CcSEcCtD
Indinavir—Urethral disorder—Doxorubicin—lung cancer	5.47e-05	0.000337	CcSEcCtD
Indinavir—Nausea—Irinotecan—lung cancer	5.46e-05	0.000336	CcSEcCtD
Indinavir—Constipation—Docetaxel—lung cancer	5.44e-05	0.000334	CcSEcCtD
Indinavir—Pain—Docetaxel—lung cancer	5.44e-05	0.000334	CcSEcCtD
Indinavir—Back pain—Methotrexate—lung cancer	5.43e-05	0.000334	CcSEcCtD
Indinavir—Pruritus—Etoposide—lung cancer	5.41e-05	0.000333	CcSEcCtD
Indinavir—Asthenia—Paclitaxel—lung cancer	5.38e-05	0.000331	CcSEcCtD
Indinavir—Nausea—Gemcitabine—lung cancer	5.32e-05	0.000327	CcSEcCtD
Indinavir—Vomiting—Cisplatin—lung cancer	5.31e-05	0.000327	CcSEcCtD
Indinavir—Pruritus—Paclitaxel—lung cancer	5.31e-05	0.000326	CcSEcCtD
Indinavir—Vision blurred—Methotrexate—lung cancer	5.29e-05	0.000325	CcSEcCtD
Indinavir—Erythema multiforme—Doxorubicin—lung cancer	5.28e-05	0.000325	CcSEcCtD
Indinavir—Rash—Cisplatin—lung cancer	5.26e-05	0.000324	CcSEcCtD
Indinavir—Dermatitis—Cisplatin—lung cancer	5.26e-05	0.000324	CcSEcCtD
Indinavir—Feeling abnormal—Docetaxel—lung cancer	5.24e-05	0.000322	CcSEcCtD
Indinavir—Diarrhoea—Etoposide—lung cancer	5.23e-05	0.000322	CcSEcCtD
Indinavir—Ill-defined disorder—Methotrexate—lung cancer	5.21e-05	0.00032	CcSEcCtD
Indinavir—Gastrointestinal pain—Docetaxel—lung cancer	5.2e-05	0.00032	CcSEcCtD
Indinavir—Anaemia—Methotrexate—lung cancer	5.19e-05	0.000319	CcSEcCtD
Indinavir—Flushing—Doxorubicin—lung cancer	5.18e-05	0.000319	CcSEcCtD
Indinavir—Diarrhoea—Paclitaxel—lung cancer	5.13e-05	0.000316	CcSEcCtD
Indinavir—Malaise—Methotrexate—lung cancer	5.06e-05	0.000311	CcSEcCtD
Indinavir—Dizziness—Etoposide—lung cancer	5.06e-05	0.000311	CcSEcCtD
Indinavir—Immune system disorder—Doxorubicin—lung cancer	5.04e-05	0.00031	CcSEcCtD
Indinavir—Vertigo—Methotrexate—lung cancer	5.04e-05	0.00031	CcSEcCtD
Indinavir—Abdominal pain—Docetaxel—lung cancer	5.03e-05	0.000309	CcSEcCtD
Indinavir—Body temperature increased—Docetaxel—lung cancer	5.03e-05	0.000309	CcSEcCtD
Indinavir—Chills—Doxorubicin—lung cancer	5.01e-05	0.000308	CcSEcCtD
Indinavir—Dizziness—Paclitaxel—lung cancer	4.96e-05	0.000305	CcSEcCtD
Indinavir—Nausea—Cisplatin—lung cancer	4.96e-05	0.000305	CcSEcCtD
Indinavir—Alopecia—Doxorubicin—lung cancer	4.93e-05	0.000304	CcSEcCtD
Indinavir—Cough—Methotrexate—lung cancer	4.9e-05	0.000301	CcSEcCtD
Indinavir—Vomiting—Etoposide—lung cancer	4.86e-05	0.000299	CcSEcCtD
Indinavir—Malnutrition—Doxorubicin—lung cancer	4.86e-05	0.000299	CcSEcCtD
Indinavir—Rash—Etoposide—lung cancer	4.82e-05	0.000297	CcSEcCtD
Indinavir—Dermatitis—Etoposide—lung cancer	4.82e-05	0.000296	CcSEcCtD
Indinavir—Headache—Etoposide—lung cancer	4.79e-05	0.000295	CcSEcCtD
Indinavir—Flatulence—Doxorubicin—lung cancer	4.79e-05	0.000295	CcSEcCtD
Indinavir—Chest pain—Methotrexate—lung cancer	4.78e-05	0.000294	CcSEcCtD
Indinavir—Arthralgia—Methotrexate—lung cancer	4.78e-05	0.000294	CcSEcCtD
Indinavir—Myalgia—Methotrexate—lung cancer	4.78e-05	0.000294	CcSEcCtD
Indinavir—Tension—Doxorubicin—lung cancer	4.77e-05	0.000293	CcSEcCtD
Indinavir—Vomiting—Paclitaxel—lung cancer	4.77e-05	0.000293	CcSEcCtD
Indinavir—Dysgeusia—Doxorubicin—lung cancer	4.76e-05	0.000293	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4.75e-05	0.000292	CcSEcCtD
Indinavir—Rash—Paclitaxel—lung cancer	4.73e-05	0.000291	CcSEcCtD
Indinavir—Dermatitis—Paclitaxel—lung cancer	4.72e-05	0.000291	CcSEcCtD
Indinavir—Discomfort—Methotrexate—lung cancer	4.72e-05	0.00029	CcSEcCtD
Indinavir—Nervousness—Doxorubicin—lung cancer	4.72e-05	0.00029	CcSEcCtD
Indinavir—Back pain—Doxorubicin—lung cancer	4.7e-05	0.000289	CcSEcCtD
Indinavir—Headache—Paclitaxel—lung cancer	4.7e-05	0.000289	CcSEcCtD
Indinavir—Hypersensitivity—Docetaxel—lung cancer	4.68e-05	0.000288	CcSEcCtD
Indinavir—Muscle spasms—Doxorubicin—lung cancer	4.67e-05	0.000287	CcSEcCtD
Indinavir—Anaphylactic shock—Methotrexate—lung cancer	4.58e-05	0.000282	CcSEcCtD
Indinavir—Vision blurred—Doxorubicin—lung cancer	4.58e-05	0.000282	CcSEcCtD
Indinavir—Asthenia—Docetaxel—lung cancer	4.56e-05	0.000281	CcSEcCtD
Indinavir—Nausea—Etoposide—lung cancer	4.54e-05	0.000279	CcSEcCtD
Indinavir—Ill-defined disorder—Doxorubicin—lung cancer	4.51e-05	0.000277	CcSEcCtD
Indinavir—Pruritus—Docetaxel—lung cancer	4.5e-05	0.000277	CcSEcCtD
Indinavir—Nervous system disorder—Methotrexate—lung cancer	4.49e-05	0.000276	CcSEcCtD
Indinavir—Anaemia—Doxorubicin—lung cancer	4.49e-05	0.000276	CcSEcCtD
Indinavir—Thrombocytopenia—Methotrexate—lung cancer	4.49e-05	0.000276	CcSEcCtD
Indinavir—Agitation—Doxorubicin—lung cancer	4.47e-05	0.000275	CcSEcCtD
Indinavir—Nausea—Paclitaxel—lung cancer	4.45e-05	0.000274	CcSEcCtD
Indinavir—Skin disorder—Methotrexate—lung cancer	4.45e-05	0.000274	CcSEcCtD
Indinavir—Hyperhidrosis—Methotrexate—lung cancer	4.43e-05	0.000272	CcSEcCtD
Indinavir—Malaise—Doxorubicin—lung cancer	4.38e-05	0.00027	CcSEcCtD
Indinavir—Vertigo—Doxorubicin—lung cancer	4.37e-05	0.000269	CcSEcCtD
Indinavir—Anorexia—Methotrexate—lung cancer	4.37e-05	0.000269	CcSEcCtD
Indinavir—Syncope—Doxorubicin—lung cancer	4.36e-05	0.000268	CcSEcCtD
Indinavir—Diarrhoea—Docetaxel—lung cancer	4.35e-05	0.000268	CcSEcCtD
Indinavir—Palpitations—Doxorubicin—lung cancer	4.3e-05	0.000264	CcSEcCtD
Indinavir—Loss of consciousness—Doxorubicin—lung cancer	4.27e-05	0.000263	CcSEcCtD
Indinavir—Cough—Doxorubicin—lung cancer	4.24e-05	0.000261	CcSEcCtD
Indinavir—Dizziness—Docetaxel—lung cancer	4.2e-05	0.000259	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Methotrexate—lung cancer	4.17e-05	0.000257	CcSEcCtD
Indinavir—Insomnia—Methotrexate—lung cancer	4.14e-05	0.000255	CcSEcCtD
Indinavir—Chest pain—Doxorubicin—lung cancer	4.14e-05	0.000255	CcSEcCtD
Indinavir—Arthralgia—Doxorubicin—lung cancer	4.14e-05	0.000255	CcSEcCtD
Indinavir—Myalgia—Doxorubicin—lung cancer	4.14e-05	0.000255	CcSEcCtD
Indinavir—Anxiety—Doxorubicin—lung cancer	4.12e-05	0.000254	CcSEcCtD
Indinavir—Paraesthesia—Methotrexate—lung cancer	4.11e-05	0.000253	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.11e-05	0.000253	CcSEcCtD
Indinavir—Discomfort—Doxorubicin—lung cancer	4.09e-05	0.000252	CcSEcCtD
Indinavir—Dyspnoea—Methotrexate—lung cancer	4.08e-05	0.000251	CcSEcCtD
Indinavir—Somnolence—Methotrexate—lung cancer	4.07e-05	0.000251	CcSEcCtD
Indinavir—Dry mouth—Doxorubicin—lung cancer	4.05e-05	0.000249	CcSEcCtD
Indinavir—Vomiting—Docetaxel—lung cancer	4.04e-05	0.000249	CcSEcCtD
Indinavir—Dyspepsia—Methotrexate—lung cancer	4.03e-05	0.000248	CcSEcCtD
Indinavir—Rash—Docetaxel—lung cancer	4.01e-05	0.000247	CcSEcCtD
Indinavir—Dermatitis—Docetaxel—lung cancer	4e-05	0.000246	CcSEcCtD
Indinavir—Decreased appetite—Methotrexate—lung cancer	3.98e-05	0.000245	CcSEcCtD
Indinavir—Headache—Docetaxel—lung cancer	3.98e-05	0.000245	CcSEcCtD
Indinavir—Oedema—Doxorubicin—lung cancer	3.97e-05	0.000244	CcSEcCtD
Indinavir—Anaphylactic shock—Doxorubicin—lung cancer	3.97e-05	0.000244	CcSEcCtD
Indinavir—Gastrointestinal disorder—Methotrexate—lung cancer	3.96e-05	0.000243	CcSEcCtD
Indinavir—Fatigue—Methotrexate—lung cancer	3.95e-05	0.000243	CcSEcCtD
Indinavir—Pain—Methotrexate—lung cancer	3.92e-05	0.000241	CcSEcCtD
Indinavir—Shock—Doxorubicin—lung cancer	3.9e-05	0.00024	CcSEcCtD
Indinavir—Nervous system disorder—Doxorubicin—lung cancer	3.89e-05	0.000239	CcSEcCtD
Indinavir—Thrombocytopenia—Doxorubicin—lung cancer	3.88e-05	0.000239	CcSEcCtD
Indinavir—Skin disorder—Doxorubicin—lung cancer	3.85e-05	0.000237	CcSEcCtD
Indinavir—Hyperhidrosis—Doxorubicin—lung cancer	3.84e-05	0.000236	CcSEcCtD
Indinavir—Anorexia—Doxorubicin—lung cancer	3.78e-05	0.000233	CcSEcCtD
Indinavir—Nausea—Docetaxel—lung cancer	3.78e-05	0.000232	CcSEcCtD
Indinavir—Feeling abnormal—Methotrexate—lung cancer	3.78e-05	0.000232	CcSEcCtD
Indinavir—Gastrointestinal pain—Methotrexate—lung cancer	3.75e-05	0.00023	CcSEcCtD
Indinavir—Urticaria—Methotrexate—lung cancer	3.64e-05	0.000224	CcSEcCtD
Indinavir—Abdominal pain—Methotrexate—lung cancer	3.62e-05	0.000223	CcSEcCtD
Indinavir—Body temperature increased—Methotrexate—lung cancer	3.62e-05	0.000223	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.61e-05	0.000222	CcSEcCtD
Indinavir—Insomnia—Doxorubicin—lung cancer	3.59e-05	0.000221	CcSEcCtD
Indinavir—Paraesthesia—Doxorubicin—lung cancer	3.56e-05	0.000219	CcSEcCtD
Indinavir—Dyspnoea—Doxorubicin—lung cancer	3.54e-05	0.000218	CcSEcCtD
Indinavir—Somnolence—Doxorubicin—lung cancer	3.53e-05	0.000217	CcSEcCtD
Indinavir—Dyspepsia—Doxorubicin—lung cancer	3.49e-05	0.000215	CcSEcCtD
Indinavir—Decreased appetite—Doxorubicin—lung cancer	3.45e-05	0.000212	CcSEcCtD
Indinavir—Gastrointestinal disorder—Doxorubicin—lung cancer	3.43e-05	0.000211	CcSEcCtD
Indinavir—Fatigue—Doxorubicin—lung cancer	3.42e-05	0.00021	CcSEcCtD
Indinavir—Pain—Doxorubicin—lung cancer	3.39e-05	0.000209	CcSEcCtD
Indinavir—Constipation—Doxorubicin—lung cancer	3.39e-05	0.000209	CcSEcCtD
Indinavir—Hypersensitivity—Methotrexate—lung cancer	3.38e-05	0.000208	CcSEcCtD
Indinavir—Asthenia—Methotrexate—lung cancer	3.29e-05	0.000202	CcSEcCtD
Indinavir—Feeling abnormal—Doxorubicin—lung cancer	3.27e-05	0.000201	CcSEcCtD
Indinavir—Gastrointestinal pain—Doxorubicin—lung cancer	3.24e-05	0.0002	CcSEcCtD
Indinavir—Pruritus—Methotrexate—lung cancer	3.24e-05	0.000199	CcSEcCtD
Indinavir—Urticaria—Doxorubicin—lung cancer	3.15e-05	0.000194	CcSEcCtD
Indinavir—Body temperature increased—Doxorubicin—lung cancer	3.14e-05	0.000193	CcSEcCtD
Indinavir—Abdominal pain—Doxorubicin—lung cancer	3.14e-05	0.000193	CcSEcCtD
Indinavir—Diarrhoea—Methotrexate—lung cancer	3.13e-05	0.000193	CcSEcCtD
Indinavir—Dizziness—Methotrexate—lung cancer	3.03e-05	0.000186	CcSEcCtD
Indinavir—Hypersensitivity—Doxorubicin—lung cancer	2.92e-05	0.00018	CcSEcCtD
Indinavir—Vomiting—Methotrexate—lung cancer	2.91e-05	0.000179	CcSEcCtD
Indinavir—Rash—Methotrexate—lung cancer	2.89e-05	0.000178	CcSEcCtD
Indinavir—Dermatitis—Methotrexate—lung cancer	2.89e-05	0.000178	CcSEcCtD
Indinavir—Headache—Methotrexate—lung cancer	2.87e-05	0.000177	CcSEcCtD
Indinavir—Asthenia—Doxorubicin—lung cancer	2.85e-05	0.000175	CcSEcCtD
Indinavir—Pruritus—Doxorubicin—lung cancer	2.81e-05	0.000173	CcSEcCtD
Indinavir—Nausea—Methotrexate—lung cancer	2.72e-05	0.000167	CcSEcCtD
Indinavir—Diarrhoea—Doxorubicin—lung cancer	2.71e-05	0.000167	CcSEcCtD
Indinavir—Dizziness—Doxorubicin—lung cancer	2.62e-05	0.000161	CcSEcCtD
Indinavir—Vomiting—Doxorubicin—lung cancer	2.52e-05	0.000155	CcSEcCtD
Indinavir—Rash—Doxorubicin—lung cancer	2.5e-05	0.000154	CcSEcCtD
Indinavir—Dermatitis—Doxorubicin—lung cancer	2.5e-05	0.000154	CcSEcCtD
Indinavir—Headache—Doxorubicin—lung cancer	2.49e-05	0.000153	CcSEcCtD
Indinavir—Nausea—Doxorubicin—lung cancer	2.36e-05	0.000145	CcSEcCtD
Indinavir—CYP2C9—Metabolism—PPP2R1B—lung cancer	6.08e-06	6.81e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.07e-06	6.81e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—APOA1—lung cancer	6.03e-06	6.76e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—POMC—lung cancer	6.01e-06	6.73e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CG—lung cancer	6e-06	6.72e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	6e-06	6.72e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	6e-06	6.72e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTT1—lung cancer	5.98e-06	6.71e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ENO1—lung cancer	5.95e-06	6.67e-05	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	5.95e-06	6.66e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—MDM2—lung cancer	5.94e-06	6.65e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—RRM1—lung cancer	5.93e-06	6.65e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTA3—lung cancer	5.93e-06	6.65e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTT1—lung cancer	5.93e-06	6.65e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—RAF1—lung cancer	5.92e-06	6.63e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GCLC—lung cancer	5.92e-06	6.63e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP2A6—lung cancer	5.92e-06	6.63e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP2A6—lung cancer	5.86e-06	6.57e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GCLC—lung cancer	5.86e-06	6.57e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CREBBP—lung cancer	5.85e-06	6.56e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—ERBB2—lung cancer	5.85e-06	6.56e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.84e-06	6.55e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTP1—lung cancer	5.83e-06	6.54e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—MTOR—lung cancer	5.78e-06	6.47e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CB—lung cancer	5.78e-06	6.47e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—CD4—lung cancer	5.77e-06	6.46e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—PTGS2—lung cancer	5.72e-06	6.41e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—POMC—lung cancer	5.71e-06	6.4e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CAT—lung cancer	5.68e-06	6.36e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—APOA1—lung cancer	5.61e-06	6.29e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ENO1—lung cancer	5.61e-06	6.28e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—B4GALT5—lung cancer	5.58e-06	6.25e-05	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	5.57e-06	6.24e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CREBBP—lung cancer	5.56e-06	6.23e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ENO1—lung cancer	5.56e-06	6.23e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CD—lung cancer	5.55e-06	6.22e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.54e-06	6.21e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ABCB1—lung cancer	5.52e-06	6.19e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CG—lung cancer	5.51e-06	6.17e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—ALB—lung cancer	5.48e-06	6.14e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP2E1—lung cancer	5.47e-06	6.13e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.47e-06	6.13e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTA4—lung cancer	5.43e-06	6.08e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—TYMS—lung cancer	5.42e-06	6.08e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—NQO1—lung cancer	5.41e-06	6.06e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CB—lung cancer	5.38e-06	6.02e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTM1—lung cancer	5.36e-06	6.01e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP2E1—lung cancer	5.34e-06	5.98e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PTGS2—lung cancer	5.33e-06	5.97e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.29e-06	5.93e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTA2—lung cancer	5.29e-06	5.93e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NQO1—lung cancer	5.28e-06	5.91e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CD—lung cancer	5.27e-06	5.91e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.25e-06	5.88e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—POMC—lung cancer	5.24e-06	5.87e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ALB—lung cancer	5.21e-06	5.83e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CG—lung cancer	5.12e-06	5.74e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CREBBP—lung cancer	5.11e-06	5.72e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTA1—lung cancer	5.1e-06	5.72e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP1A1—lung cancer	5.08e-06	5.69e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ABCC3—lung cancer	5.05e-06	5.65e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ERCC2—lung cancer	5.04e-06	5.65e-05	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	5.03e-06	5.64e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP2E1—lung cancer	5.03e-06	5.64e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—CDKN1A—lung cancer	5e-06	5.61e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—PTEN—lung cancer	4.99e-06	5.59e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP2E1—lung cancer	4.99e-06	5.59e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NQO1—lung cancer	4.97e-06	5.57e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NQO1—lung cancer	4.93e-06	5.52e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKR1C1—lung cancer	4.89e-06	5.48e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—POMC—lung cancer	4.88e-06	5.47e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—STK11—lung cancer	4.87e-06	5.46e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CD—lung cancer	4.84e-06	5.42e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CB—lung cancer	4.84e-06	5.42e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.83e-06	5.41e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTGS2—lung cancer	4.79e-06	5.37e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.78e-06	5.36e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ALB—lung cancer	4.78e-06	5.35e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—EP300—lung cancer	4.76e-06	5.33e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—STK11—lung cancer	4.76e-06	5.33e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CREBBP—lung cancer	4.75e-06	5.32e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—UGT1A1—lung cancer	4.74e-06	5.32e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PTEN—lung cancer	4.65e-06	5.21e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—SRC—lung cancer	4.63e-06	5.19e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CB—lung cancer	4.6e-06	5.15e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.58e-06	5.13e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GNG11—lung cancer	4.57e-06	5.13e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTGS2—lung cancer	4.56e-06	5.1e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTP1—lung cancer	4.51e-06	5.05e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CD—lung cancer	4.5e-06	5.05e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—STK11—lung cancer	4.48e-06	5.02e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—STAT3—lung cancer	4.46e-06	5e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—NRAS—lung cancer	4.45e-06	4.99e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ALB—lung cancer	4.45e-06	4.98e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—STK11—lung cancer	4.44e-06	4.98e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—EP300—lung cancer	4.43e-06	4.96e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTP1—lung cancer	4.4e-06	4.93e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CAT—lung cancer	4.39e-06	4.92e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.36e-06	4.89e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—APOA1—lung cancer	4.36e-06	4.89e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALDOA—lung cancer	4.36e-06	4.88e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CAT—lung cancer	4.28e-06	4.8e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ABCB1—lung cancer	4.27e-06	4.78e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—MAPK3—lung cancer	4.27e-06	4.78e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NCOA3—lung cancer	4.23e-06	4.74e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CB—lung cancer	4.22e-06	4.73e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—TYMS—lung cancer	4.19e-06	4.7e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTGS2—lung cancer	4.18e-06	4.68e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTEN—lung cancer	4.18e-06	4.68e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.17e-06	4.67e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—MYC—lung cancer	4.15e-06	4.65e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTP1—lung cancer	4.15e-06	4.65e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTM1—lung cancer	4.14e-06	4.64e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ADCY1—lung cancer	4.11e-06	4.61e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ABCG2—lung cancer	4.11e-06	4.61e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTP1—lung cancer	4.11e-06	4.61e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—TYMS—lung cancer	4.09e-06	4.59e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—EGFR—lung cancer	4.06e-06	4.55e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTM1—lung cancer	4.05e-06	4.53e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CAT—lung cancer	4.04e-06	4.52e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ENO2—lung cancer	4.03e-06	4.52e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HPGDS—lung cancer	4.03e-06	4.52e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.01e-06	4.49e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CAT—lung cancer	4e-06	4.48e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—EP300—lung cancer	3.99e-06	4.47e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CG—lung cancer	3.98e-06	4.46e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.98e-06	4.46e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTEN—lung cancer	3.97e-06	4.45e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP1A1—lung cancer	3.93e-06	4.4e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CB—lung cancer	3.93e-06	4.4e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ABCB1—lung cancer	3.93e-06	4.4e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTT1—lung cancer	3.91e-06	4.38e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ERCC2—lung cancer	3.9e-06	4.37e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ABCB1—lung cancer	3.89e-06	4.36e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTGS2—lung cancer	3.89e-06	4.36e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GCLC—lung cancer	3.87e-06	4.33e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP2A6—lung cancer	3.87e-06	4.33e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—TYMS—lung cancer	3.86e-06	4.32e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP1A1—lung cancer	3.83e-06	4.3e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—KRAS—lung cancer	3.83e-06	4.29e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—TYMS—lung cancer	3.82e-06	4.28e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTM1—lung cancer	3.81e-06	4.27e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ERCC2—lung cancer	3.8e-06	4.26e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—POMC—lung cancer	3.79e-06	4.25e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—EP300—lung cancer	3.79e-06	4.25e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTM1—lung cancer	3.78e-06	4.23e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CREBBP—lung cancer	3.69e-06	4.14e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ENO1—lung cancer	3.67e-06	4.11e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTEN—lung cancer	3.65e-06	4.09e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP1A1—lung cancer	3.61e-06	4.05e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ERCC2—lung cancer	3.58e-06	4.02e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP1A1—lung cancer	3.58e-06	4.01e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ERCC2—lung cancer	3.55e-06	3.98e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CA—lung cancer	3.52e-06	3.95e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CD—lung cancer	3.5e-06	3.92e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—EP300—lung cancer	3.48e-06	3.9e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ALB—lung cancer	3.45e-06	3.87e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTEN—lung cancer	3.39e-06	3.8e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—APOA1—lung cancer	3.37e-06	3.78e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—APOA1—lung cancer	3.29e-06	3.69e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP2E1—lung cancer	3.29e-06	3.68e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CA—lung cancer	3.28e-06	3.67e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—HRAS—lung cancer	3.26e-06	3.65e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NQO1—lung cancer	3.25e-06	3.64e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—EP300—lung cancer	3.24e-06	3.63e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.23e-06	3.62e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—IL6—lung cancer	3.12e-06	3.49e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—APOA1—lung cancer	3.1e-06	3.47e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CG—lung cancer	3.08e-06	3.45e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—APOA1—lung cancer	3.07e-06	3.44e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CB—lung cancer	3.05e-06	3.42e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTGS2—lung cancer	3.02e-06	3.39e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CG—lung cancer	3e-06	3.37e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CA—lung cancer	2.95e-06	3.3e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.94e-06	3.3e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—STK11—lung cancer	2.93e-06	3.28e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—POMC—lung cancer	2.93e-06	3.28e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—AKT1—lung cancer	2.88e-06	3.22e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—POMC—lung cancer	2.86e-06	3.2e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CREBBP—lung cancer	2.85e-06	3.2e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CG—lung cancer	2.83e-06	3.17e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CG—lung cancer	2.81e-06	3.14e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CA—lung cancer	2.8e-06	3.14e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CREBBP—lung cancer	2.78e-06	3.12e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTP1—lung cancer	2.71e-06	3.04e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CD—lung cancer	2.71e-06	3.03e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—POMC—lung cancer	2.69e-06	3.02e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—AKT1—lung cancer	2.68e-06	3e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—POMC—lung cancer	2.67e-06	2.99e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ALB—lung cancer	2.67e-06	2.99e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CD—lung cancer	2.64e-06	2.96e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CAT—lung cancer	2.64e-06	2.96e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTEN—lung cancer	2.64e-06	2.95e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CREBBP—lung cancer	2.62e-06	2.94e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ALB—lung cancer	2.61e-06	2.92e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CREBBP—lung cancer	2.6e-06	2.92e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CA—lung cancer	2.57e-06	2.88e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ABCB1—lung cancer	2.57e-06	2.88e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—TYMS—lung cancer	2.52e-06	2.83e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—EP300—lung cancer	2.51e-06	2.82e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTM1—lung cancer	2.49e-06	2.79e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CD—lung cancer	2.49e-06	2.79e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CD—lung cancer	2.47e-06	2.76e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ALB—lung cancer	2.46e-06	2.75e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ALB—lung cancer	2.44e-06	2.73e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—AKT1—lung cancer	2.41e-06	2.7e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CA—lung cancer	2.39e-06	2.68e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP1A1—lung cancer	2.36e-06	2.65e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CB—lung cancer	2.36e-06	2.64e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ERCC2—lung cancer	2.34e-06	2.63e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTGS2—lung cancer	2.34e-06	2.62e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CB—lung cancer	2.3e-06	2.58e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AKT1—lung cancer	2.29e-06	2.57e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTGS2—lung cancer	2.28e-06	2.56e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CB—lung cancer	2.17e-06	2.43e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CB—lung cancer	2.15e-06	2.41e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTGS2—lung cancer	2.15e-06	2.41e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTGS2—lung cancer	2.13e-06	2.39e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AKT1—lung cancer	2.1e-06	2.35e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTEN—lung cancer	2.04e-06	2.28e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—APOA1—lung cancer	2.03e-06	2.27e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTEN—lung cancer	1.99e-06	2.23e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AKT1—lung cancer	1.96e-06	2.19e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—EP300—lung cancer	1.94e-06	2.18e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—EP300—lung cancer	1.9e-06	2.13e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTEN—lung cancer	1.87e-06	2.1e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CA—lung cancer	1.86e-06	2.08e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTEN—lung cancer	1.86e-06	2.08e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CG—lung cancer	1.85e-06	2.07e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—EP300—lung cancer	1.79e-06	2e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—EP300—lung cancer	1.77e-06	1.99e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—POMC—lung cancer	1.76e-06	1.97e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CREBBP—lung cancer	1.72e-06	1.92e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CD—lung cancer	1.63e-06	1.82e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALB—lung cancer	1.61e-06	1.8e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AKT1—lung cancer	1.52e-06	1.7e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CA—lung cancer	1.44e-06	1.61e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CB—lung cancer	1.42e-06	1.59e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTGS2—lung cancer	1.4e-06	1.57e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CA—lung cancer	1.4e-06	1.57e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CA—lung cancer	1.32e-06	1.48e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CA—lung cancer	1.31e-06	1.47e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTEN—lung cancer	1.23e-06	1.37e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AKT1—lung cancer	1.17e-06	1.32e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—EP300—lung cancer	1.17e-06	1.31e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AKT1—lung cancer	1.15e-06	1.28e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AKT1—lung cancer	1.08e-06	1.21e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AKT1—lung cancer	1.07e-06	1.2e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CA—lung cancer	8.64e-07	9.69e-06	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKT1—lung cancer	7.06e-07	7.91e-06	CbGpPWpGaD
